4 Firms Look To Build $1B Sale Of Evergreen Theragnostics
By Jade Martinez-Pogue · January 28, 2025, 1:53 PM EST
Radiopharmaceutical-focused healthcare company Lantheus Holdings Inc. on Tuesday announced plans to buy Evergreen Theragnostics Inc. for up to $1 billion or more in a deal steered by four law firms....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login